Yu Yi-Qun, Yang Xue, Wu Xiao-Fang, Fan Yi-Bin
Scientific Research and Education Department, Chun'an First People's Hospital (Zhejiang Provincial People's Hospital Chun'an Branch), Hangzhou, China.
Nursing Department, Chun'an First People's Hospital (Zhejiang Provincial People's Hospital Chun'an Branch), Hangzhou, China.
Front Bioeng Biotechnol. 2021 Mar 29;9:646554. doi: 10.3389/fbioe.2021.646554. eCollection 2021.
The transdermal route of administration provides numerous advantages over conventional routes i.e., oral or injectable for the treatment of different diseases and cosmetics applications. The skin also works as a reservoir, thus deliver the penetrated drug for more extended periods in a sustained manner. It reduces toxicity and local irritation due to multiple sites for absorption and owes the option of avoiding systemic side effects. However, the transdermal route of delivery for many drugs is limited since very few drugs can be delivered at a viable rate using this route. The stratum corneum of skin works as an effective barrier, limiting most drugs' penetration posing difficulty to cross through the skin. Fortunately, some non-invasive methods can significantly enhance the penetration of drugs through this barrier. The use of nanocarriers for increasing the range of available drugs for the transdermal delivery has emerged as a valuable and exciting alternative. Both the lipophilic and hydrophilic drugs can be delivered via a range of nanocarriers through the stratum corneum with the possibility of having local or systemic effects to treat various diseases. In this review, the skin structure and major obstacle for transdermal drug delivery, different nanocarriers used for transdermal delivery, i.e., nanoparticles, ethosomes, dendrimers, liposomes, etc., have been discussed. Some recent examples of the combination of nanocarrier and physical methods, including iontophoresis, ultrasound, laser, and microneedles, have also been discussed for improving the therapeutic efficacy of transdermal drugs. Limitations and future perspectives of nanocarriers for transdermal drug delivery have been summarized at the end of this manuscript.
与传统给药途径(即口服或注射)相比,经皮给药途径在治疗不同疾病和化妆品应用方面具有诸多优势。皮肤还可作为一个储库,从而以持续的方式在更长时间内递送渗透进去的药物。它减少了因多个吸收部位导致的毒性和局部刺激,并且具有避免全身副作用的选择。然而,许多药物的经皮给药途径受到限制,因为使用这种途径能够以可行速率递送的药物非常少。皮肤的角质层起着有效的屏障作用,限制了大多数药物的渗透,给药物穿过皮肤造成困难。幸运的是,一些非侵入性方法可以显著增强药物透过这一屏障的渗透能力。使用纳米载体来扩大可用于经皮递送的药物范围已成为一种有价值且令人兴奋的替代方法。亲脂性和亲水性药物都可以通过一系列纳米载体穿过角质层进行递送,有可能产生局部或全身作用来治疗各种疾病。在本综述中,讨论了皮肤结构和经皮给药的主要障碍、用于经皮递送的不同纳米载体,即纳米颗粒、醇质体、树枝状大分子、脂质体等。还讨论了纳米载体与物理方法(包括离子导入、超声、激光和微针)相结合的一些最新实例,以提高经皮药物的治疗效果。本手稿末尾总结了纳米载体用于经皮给药的局限性和未来展望。